Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SCANDIDERMA AS
AS
Active
Org 895238902
Stakkevollvegen 51, 9010
Tromsø
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2010 · 16 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Manufacture of basic pharmaceutical products
/
SCANDIDERMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
EM
Edel Margrete Kandal
Board of Directors
Board of Directors
2016
KH
Kai-Hugo Hebnes
Board of Directors
Board of Directors
2016
GH
Geir Håvard Kvalheim
Chairman
Chairman
2016
CS
Carstein Seeberg
Board of Directors
Board of Directors
2016
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ghk Invest As
Company
35.25%
35.25%
2025
Kandal Invest As
Company
19.17%
19.17%
2025
Seeberg Holding As
Company
14.15%
14.15%
2025
Impeto As
Company
6.01%
6.01%
2025
Montecristo Inv. International
Company
5%
5%
2025
Ingmar Fimreite
Individual
4.15%
4.15%
2025
Jacek Bartosik
Company
4.15%
4.15%
2025
R3 Holding As
Company
2.07%
2.07%
2025
Lavold Invest As
Company
2.07%
2.07%
2025
Drug Discovery Laboratory As
Company
2.07%
2.07%
2025
Arild Rune Klakegg
Individual
1.87%
1.87%
2025
Fimreite As
Company
1.2%
1.2%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on SCANDIDERMA AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network